Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera
Clinical trial NCT02410278 · COMPLETED
Trial details
- NCT number
- NCT02410278
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-12
- Primary completion
- 2017-02-16
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.